Repurposing of FDA-approved NSAIDs for DPP-4 inhibition as an alternative for diabetes mellitus treatment: Computational and in vitro study

Veera C.S.R. Chittepu, Poonam Kalhotra, Tzayhri Osorio-Gallardo, Tzayhri Gallardo-Velázquez, Guillermo Osorio-Revilla

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Repurposing of FDA-approved NSAIDs for DPP-4 inhibition as an alternative for diabetes mellitus treatment: Computational and in vitro study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry